Ledger.Open graph →
SEC Form D · Amendment · filed April 3, 2019

GeneTx Biotherapeutics LLC

Offering
$6.3M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Downers Grove, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Michael Hanrahan · Downers Grove, ILDirectorAllyson Berent · Downers Grove, ILExec · DirectorPaula Evans · Downers Grove, ILExec · DirectorJohn Lewis · N/A, Hong KongExec · DirectorMichael Hanrahan · Downers Grove, ILDirectorVor Capital LLP · LONDON, United KingdomExec · DirectorBrian M. Beitner · Boulder, CODirectorRobert W. Baird & Co. M. Incorporated · Milwaukee, WIExec · DirectorICONIQ Strategic Partners IV GP LP · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗